Fumagalli, Giorgio Giulio

Fumagalli, Giorgio Giulio  

Psicologia e scienze cognitive (29/10/12-)  

Mostra records
Risultati 1 - 20 di 144 (tempo di esecuzione: 0.05 secondi).
Titolo Anno di pubblicazione Autori Unitn File
A 66-year-old patient with vanishing white matter disease due to the p.ala87val eif2b3 mutation 1-gen-2012 Fumagalli G. G. +
A data-driven disease progression model of fluid biomarkers in genetic frontotemporal dementia 1-gen-2022 Fumagalli G. +
A modified Camel and Cactus Test detects presymptomatic semantic impairment in genetic frontotemporal dementia within the GENFI cohort 1-gen-2020 Fumagalli G. +
A Novel Automated Chemiluminescence Method for Detecting Cerebrospinal Fluid Amyloid-Beta 1-42 and 1-40, Total Tau and Phosphorylated-Tau: Implications for Improving Diagnostic Performance in Alzheimer’s Disease 1-gen-2022 Giorgio G. Fumagalli +
A novel MAPT mutation associated with the clinical phenotype of progressive nonfluent aphasia 1-gen-2011 Fumagalli G. G. +
A panel of CSF proteins separates genetic frontotemporal dementia from presymptomatic mutation carriers: a GENFI study 1-gen-2021 Fumagalli G. +
Accuracy of the clinical diagnosis of dementia with Lewy bodies (DLB) among the Italian Dementia Centers: a study by the Italian DLB study group (DLB-SINdem) 1-gen-2022 Fumagalli G. G. +
Age at symptom onset and death and disease duration in genetic frontotemporal dementia: an international retrospective cohort study 1-gen-2020 Fumagalli G. G. +
Alemtuzumab in multiple sclerosis during the COVID-19 pandemic: A mild uncomplicated infection despite intense immunosuppression 1-gen-2020 Fumagalli G. G. +
Alzheimer's disease diagnosis: Discrepancy between clinical, neuroimaging, and cerebrospinal fluid biomarkers criteria in an Italian cohort of geriatric outpatients: A retrospective cross-sectional study 1-gen-2017 Fumagalli G. G. +
Amyloid PET as a marker of normal-appearing white matter early damage in multiple sclerosis: correlation with CSF β-amyloid levels and brain volumes 1-gen-2019 Fumagalli G. G. +
Amyloid PET imaging and dementias: potential applications in detecting and quantifying early white matter damage 1-gen-2022 Fumagalli G. G. +
An Automated Toolbox to Predict Single Subject Atrophy in Presymptomatic Granulin Mutation Carriers 1-gen-2022 Giorgio Fumagalli +
Analysis of brain atrophy and local gene expression in genetic frontotemporal dementia 1-gen-2020 Fumagalli G. +
Analysis of C9orf72 Intermediate Alleles in a Retrospective Cohort of Neurological Patients: Risk Factors for Alzheimer's Disease? 1-gen-2021 Fumagalli G. G. +
Anomia is present pre-symptomatically in frontotemporal dementia due to MAPT mutations 1-gen-2022 Giorgio Fumagalli +
Apathy in presymptomatic genetic frontotemporal dementia predicts cognitive decline and is driven by structural brain changes 1-gen-2021 Giorgio Fumagalli +
Aquaporin-4 cerebrospinal fluid levels are higher in neurodegenerative dementia: looking at glymphatic system dysregulation 1-gen-2022 Fumagalli, Giorgio Giulio +
Association between enlarged perivascular spaces and cerebrospinal fluid aquaporin-4 and tau levels: report from a memory clinic 1-gen-2023 Fumagalli, Giorgio Giulio +
Association of Superficial White Matter Alterations with Cerebrospinal Fluid Biomarkers and Cognitive Decline in Neurodegenerative Dementia 1-gen-2022 Fumagalli G. G. +